Accession Number: | 0001562180-20-004687 |
Date: | 2020-06-23 |
Issuer: | PIERIS PHARMACEUTICALS, INC. (PIRS) |
Original Submission Date: |
GERAGHTY JAMES A
C/O PIERIS PHARMACEUTICALS, INC.
255 STATE STREET 9TH FLOOR
BOSTON, MA 02109
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 3.27 | 2020-06-23 | deemed execution date | A | 45,000 (a) | 2030-06-23 | common stock 45,000 | $3.27 | 45,000 | direct |
ID | footnote |
---|---|
f1 | the stock option will vest as to 100% of the underlying shares on june 23, 2021, subject to the reporting person's continued service as a director through the vesting date. |